NT$ 103
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Caliway Biopharmaceuticals Co., Ltd., established in 2012 and headquartered in New Taipei City, Taiwan, specializes in the development of small-molecule therapeutics designed to address both medical aesthetic and inflammatory conditions.
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks.
Data is available to registered users only